Literature DB >> 1349393

Clinical importance of HCV confirmatory testing in blood donors.

J P Allain, A Rankin, M C Kuhns, A McNamara.   

Abstract

Mesh：

Year:  1992        PMID： 1349393     DOI： 10.1016/0140-6736(92)90772-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes.

Authors:  N N Zein; J J Germer; N K Wendt; C M Schimek; J N Thorvilson; P S Mitchell; D H Persing
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Hepatitis C virus: epidemiology and genotypes in the north east of England.

Authors:  J P Watson; A M Brind; C E Chapman; C L Bates; F K Gould; S J Johnson; A D Burt; J Ferguson; P Simmonds; M F Bassendine
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

4.  Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.

Authors:  J M Pawlotsky; A Fleury; V Choukroun; L Deforges; F Roudot-Thoraval; P Aumont; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.